RT @spenafajuri: No hay que obnubilarse con las bases de datos mega-gigantes. N gigante disminuye el error aleatorio, pero no el error sist…
RT @spenafajuri: No hay que obnubilarse con las bases de datos mega-gigantes. N gigante disminuye el error aleatorio, pero no el error sist…
RT @spenafajuri: No hay que obnubilarse con las bases de datos mega-gigantes. N gigante disminuye el error aleatorio, pero no el error sist…
RT @spenafajuri: No hay que obnubilarse con las bases de datos mega-gigantes. N gigante disminuye el error aleatorio, pero no el error sist…
No hay que obnubilarse con las bases de datos mega-gigantes. N gigante disminuye el error aleatorio, pero no el error sistemático. Más que nunca es vital la distinción entre el efecto estadístico y el poblacional/clínico https://t.co/tqvgBfFVpo
RT @EhrensteinVera: One good byproduct of large studies may be that all results will be statistically significant, forcing us to focus on v…
RT @EhrensteinVera: One good byproduct of large studies may be that all results will be statistically significant, forcing us to focus on v…
RT @EhrensteinVera: One good byproduct of large studies may be that all results will be statistically significant, forcing us to focus on v…
RT @EhrensteinVera: One good byproduct of large studies may be that all results will be statistically significant, forcing us to focus on v…
One good byproduct of large studies may be that all results will be statistically significant, forcing us to focus on validity and clinical significance instead https://t.co/sBQ8ELFaRN https://t.co/qgMD9TxQht
@EpidemiologyLWW Agreed, and we have argued similarly https://t.co/sBQ8ELFaRN
This article does a wonderful job of intruding big data in public health and the concerns. https://t.co/PZxF4DE1M5 #UconnBigDataBiology
RT @berglund_anita: Perils & Pitfalls - big data for clinical epidemiology. @JClinEpi https://t.co/qfOa8Tj7Mw #BigData #Epidemiology #Respo…
Perils & Pitfalls - big data for clinical epidemiology. @JClinEpi https://t.co/qfOa8Tj7Mw #BigData #Epidemiology #Responsibility
RT @BrianSMcGowan: Clinical epidemiology in the era of big data: new opportunities, familiar challenges https://t.co/f7GwfbtsdF #socialQI #…
Clinical epidemiology in the era of big data: new opportunities, familiar challenges https://t.co/f7GwfbtsdF #socialQI #hcsm #bigdata #meded
RT: (cor_marti) Clinical epidemiology in the era of big data: new opportunities, familiar challenges #digitalheal… https://t.co/glvzZbDqxC
Clinical epidemiology in the era of big data: new opportunities, familiar challenges #digitalhealth #bigdata https://t.co/Dj8knozVTC
RT @doctick: #BigData "Clinical epidemiology in the era of big data: new opportunities, familiar challenges." https://t.co/xwOnnkeljM
#BigData "Clinical epidemiology in the era of big data: new opportunities, familiar challenges." https://t.co/xwOnnkeljM
RT @dceaarhus: New paper from DCE colleagues #clinicalepidemiology #bigdata @EhrensteinVera @AlmaBPedersen @lapdce73 et al. https://t.co/HA…
RT @dceaarhus: New paper from DCE colleagues #clinicalepidemiology #bigdata @EhrensteinVera @AlmaBPedersen @lapdce73 et al. https://t.co/HA…
RT @dceaarhus: New paper from DCE colleagues #clinicalepidemiology #bigdata @EhrensteinVera @AlmaBPedersen @lapdce73 et al. https://t.co/HA…
New paper from DCE colleagues #clinicalepidemiology #bigdata @EhrensteinVera @AlmaBPedersen @lapdce73 et al. https://t.co/HAUbFgDmOO
RT @DovePress: Clinical epidemiology in the era of big data: new opportunities, familiar challenges https://t.co/N32sxWXjrZ https://t.co/co…
Clinical epidemiology in the era of big data: new opportunities, familiar challenges https://t.co/N32sxWXjrZ https://t.co/cooomYIYma
RT @joshinav: “Clinical epidemiology in the era of #BigData : new opportunities, familiar challenges” https://t.co/wlm4yjvRVb